Supplemental Table 1. Patient Characteristics: Open Label and Randomized Double Blind Phase I/II Trial

Published: 15 December 2023| Version 1 | DOI: 10.17632/xx9b9bkzy7.1
Contributor:
Guy Goldman

Description

Supplemental Table 1. Patient Characteristics: Open Label and Randomized Double Blind Phase I/II Trial

Files

Categories

Breast Cancer

Funding

Lutris Pharma

Licence